CAMP4 Therapeutics Corporation
USD4.20
+0.28 (+7.14%)
CEO
Joshua Mandel-Brehm
IPO Date
2024-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.03
Prev. Close
$3.92
Day Low
$3.82
Day High
$4.31
52W Low
$1.32
52W High
$7.75
Market Cap
$0.09B
Volume
3.94M
| 28,000 |
| $4.34 |
| 12 Jun 2026 | Schwab Andrew J. | director, 10 percent owner: | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Holtzman Steven H | director | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Stewart Murray | director | A-Award | Acquired | 28,000 | $4.34 |
| 12 Jun 2026 | Nashat Amir | director, 10 percent owner: | A-Award | Acquired | 28,000 | $4.34 |
| 3 Apr 2026 | Tardiff Daniel | Chief Scientific Officer | A-Award | Acquired | 170,000 | $4.46 |
| 3 Apr 2026 | Maricich Yuri | Chief Medical Officer | A-Award | Acquired | 215,000 | $4.46 |
| 3 Apr 2026 | Gold Kelly | Chief Financial Officer | A-Award | Acquired | 215,000 | $4.46 |
| 3 Apr 2026 | Mandel-Brehm Josh | director, officer: Chief Executive Officer | A-Award | Acquired | 580,000 | $4.46 |